Register

COURSE DESCRIPTION:  

Most cardiac amyloidosis cases are due to immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR). Amyloid-induced cardiomyopathy has distinct characteristics compared to non-amyloid cardiomyopathies. As a result, specific management strategies are needed. In this lecture, Dr. Bush will review the pathophysiology and subtypes of cardiac amyloidosis and discuss the available and emerging therapies.

TARGET AUDIENCE:

Internal Medicine Physicians, Physician Assistants, Residents,  Advanced Practice Registered Nurses, Pharmacists and all other interested healthcare providers. 

LEARNING OBJECTIVES:

  • Review the pathophysiology and subtypes of cardiac amyloidosis.
  • Establish the clinical clues for when to suspect cardiac amyloidosis.
  • Highlight and discuss the key principles in making the diagnosis of cardiac amyloidosis.
  • Discuss the available and emerging therapies for cardiac amyloidosis.

FACULTY AND DISCLOSURES:

Aaron L. Bush, M.D., FACC, FSCAI
Cardiologist/Interventional Cardiologist
Boca Raton Regional Hospital
Baptist Health of South Florida
Boca Raton, Florida

Aaron L. Bush, M.D., FACC, FSCAI, faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.  

Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855339, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.

Session date: 
05/17/2022 - 7:30am to 8:30am EDT
Location: 
Zoom
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Athletic Training
  • 1.00 General certificate of attendance
  • 1.00 Florida Board of Dentistry
  • 1.00 Florida Board of Dietitians
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Pharmacy

Please login or register to take this course.